Key result
Age is a significant independent predictor of thromboembolic events in patients with atrial fibrillation (OR 1.031; P<0.001), associated with adverse cardiac hemodynamics regardless of CHA2DS2-VASc score.
Why the study?
Age is a well-established risk factor for thromboembolic events in patients with AF, but the underlying mechanism remains unknown.
Does age independently predict thromboembolic events and adverse cardiac hemodynamics in patients with non-valvular atrial fibrillation?
Cohort (n=8,697)
Yes
Does age independently predict thromboembolic events and adverse cardiac hemodynamics in patients with non-valvular atrial fibrillation?
Age is a significant independent predictor of thromboembolic events in patients with atrial fibrillation, driven by adverse cardiac hemodynamics, regardless of the CHA2DS2-VASc score.
Background Age is a well‐established risk factor for thromboembolic events in patients with atrial fibrillation (AF). However, the mechanism underlying the association between age and thromboembolic events in AF remains unknown. Methods The prognostic value of age as a risk factor for thromboembolic events was analyzed using data from the Korean National Health Insurance Service (NHIS). In a large‐scale single‐center registry, cardiac hemodynamic parameters were examined to elucidate the cause of increased risk of thromboembolic events in older patients. Results NHIS sample cohort data including 5896 patients with AF revealed that the risk of thromboembolic complication differed significantly according to age despite equal CHA2DS2‐VASc score. In the registry of 2801 patients, age showed significant correlations with left atrium (LA) diameter, LA volume, E/e′, pulmonary artery pressure, and LA appendage flow velocity. Older patients had a significantly higher prevalence of spontaneous echocontrast (odds ratio [OR] = 1.030; P < .001). Age (OR = 1.031; P < .001), E/e′ (OR = 1.065; P = .004), and LA appendage flow velocity (OR = .988; P = .009) were significant predictors for thromboembolic events in multivariate analyses. In data from the NHIS, CHA2DS2‐VASc score did not outperform age to predict thromboembolic events. Conclusions Age is a significant risk factor for thromboembolic events in patients with AF, and old age is associated with adverse cardiac hemodynamics. This study suggests that older patients with AF are at high risk of thromboembolic events regardless of CHA2DS2‐VASc score.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2019) conducted a cohort in Non-valvular atrial fibrillation (n=8,697). Age was evaluated on Thromboembolic events (OR 1.031, p=<0.001). Age is a significant independent predictor of thromboembolic events in patients with atrial fibrillation (OR 1.031; P<0.001), associated with adverse cardiac hemodynamics regardless of CHA2DS2-VASc score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Atrial fibrillationMore from Clinical Cardiology